StockMarketWire.com - 4D pharma said Wednesday it was not aware of any company related matter contributing to the recent fall in its share price, and confirmed that all clinical study timelines continued to progress as expected.


At 9:59am: [LON:DDDD] 4d Pharma Plc Ord 0.25p share price was +4.5p at 93.5p



Story provided by StockMarketWire.com